Garon EB, Spira AI, Johnson M, Bazhenova L, et al. A phase 1b open-label, multicenter study of inhaled DV281, a TLR9 agonist, in combination with nivolumab in patients with advanced or metastatic non-small cell lung cancer. Clin Cancer Res 2021 Jun 9. pii: 1078-0432.CCR-21-0263.
PMID: 34108179